Predicting the location of human perirhinal cortex, Brodmann's area 35, from MRI

Jean C Augustinack1, Kristen E Huber, Allison A Stevens

  • 1Athinoula A Martinos Center, Dept. of Radiology, MGH, 149 13th Street, Charlestown MA 02129 USA. jean@nmr.mgh.harvard.edu

Neuroimage
|September 11, 2012
PubMed

Insights

This study developed an accurate method to map the perirhinal cortex (area 35) in ex vivo brain hemispheres. This technique aids in detecting early Alzheimer's disease changes by measuring cortical thickness in this memory-critical region.

Area of Science:

  • Neuroimaging
  • Neuroanatomy
  • Alzheimer's Disease Research

Background:

  • The perirhinal cortex (Brodmann's area 35) is crucial for memory and object recognition.
  • It is an early site of neurofibrillary tangles in Alzheimer's disease.

Purpose of the Study:

  • To develop and validate an ex vivo probabilistic mapping method for the perirhinal cortex (area 35).
  • To enable automated and accurate labeling of architectonic regions in the medial temporal lobe.
  • To facilitate the analysis of atrophic changes for earlier Alzheimer's disease detection.

Main Methods:

  • High-resolution ex vivo MRI scanning of brain hemispheres.
  • Construction of pial/white matter surfaces using FreeSurfer.
  • Labeling of area 35 and mapping to surface models, validated with Nissl staining.
  • Accuracy assessment using Hausdorff distance.

Main Results:

  • Probabilistic mapping of perirhinal cortex (area 35) achieved median Hausdorff distances of 4.0mm (left) and 3.2mm (right) hemispheres.
  • Demonstrated utility by mapping to the Alzheimer's Disease Neuroimaging Initiative dataset.
  • Found decreased cortical thickness in mild cognitive impairment and Alzheimer's disease patients within area 35 compared to controls.

Conclusions:

  • Ex vivo probabilistic mapping provides histologically validated, automated, and accurate labeling of the perirhinal cortex.
  • This method is valuable for analyzing atrophic changes in large datasets for earlier Alzheimer's disease diagnosis.
  • Facilitates research into memory function and neurodegenerative diseases affecting the medial temporal lobe.

Related Concept Videos